drugset

drugset / Trial / NCT00192348

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants

NCT00192348 ↗

Phase 1 Completed 120 enrolled MedImmune LLC Wyeth is now a wholly owned subsidiary of Pfizer · collab

RandomizedSingle-groupDouble-blindTreatment

Summary

Trial to compare the safety and tolerability of one and two doses of influenza virus vaccine.

Timeline

Start: 2002-05
Primary completion: —
Completion: 2002-12

Publications

Vesikari T, Karvonen A, Smith HM, Dunning A, Razmpour A, Saville MK, Gruber WC, Forrest BD. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Pediatrics. 2008 Mar;121(3):e568-73. doi: 10.1542/peds.2007-1405. Epub 2008 Feb 25.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	FluMist	Vaccine	—	Intranasal

Indications

No indication recorded.